Judith Greciet is the founder of Onxeo. Onxeo has raised $14M in total funding. Latest round: Series B. Backed by Capital Ventures, Nyenburgh.
Judith Greciet is the CEO and Director General of Onxeo, a biopharmaceutical company specializing in innovative drugs for orphan diseases, with a focus on oncology. She has overseen significant capital raises for the company, including a €12.5 million round in 2016.
Full founder directory · Investor directory · Company funding database · Fundraising library